Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Appointed CFO
Director departure
Inv. presentation

Targeted Medical Pharma, Inc. (TRGM) Create: Alert

All | News | Filings
Date FiledTypeDescription
05/17/2019 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
01/22/2019 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
10/18/2018 15-12G Form 15-12G - Securities registration termination [Section 12(g)]:
12/12/2017 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
04/14/2016 10-K Annual Report for the period ended December 31, 2015
03/31/2016 NT 10-K Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405
03/08/2016 4 Wenkart Thomas Richard (10% Owner) has filed a Form 4 on Targeted Medical Pharma, Inc.
03/07/2016 4 Weems Kerry Neil (Director) has filed a Form 4 on Targeted Medical Pharma, Inc.
Txns: Granted 200,000 shares @ $0.05, valued at $10k
Granted 100,000 options to buy @ $0.05, valued at $5k
03/07/2016 4 Silver David Samuel (Chief Medical Officer) has filed a Form 4 on Targeted Medical Pharma, Inc.
Txns: Granted 575,000 shares @ $0.05, valued at $28.8k
Disposed of 177,469 options to buy @ $3.38, valued at $599.8k
Disposed of 400,000 options to buy @ $3.38, valued at $1.4M
Granted 400,000 options to buy @ $0.05, valued at $20k
03/07/2016 4 Giffoni Kim (CEO) has filed a Form 4 on Targeted Medical Pharma, Inc.
Txns: Granted 547,500 shares @ $0.05, valued at $27.4k
Granted 300,000 options to buy @ $0.05, valued at $15k
03/07/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
03/07/2016 4 Horne William B (CFO) has filed a Form 4 on Targeted Medical Pharma, Inc.
02/16/2016 SC 13G/A DERMA MEDICAL SYSTEMS INC. has filed a Schedule 13D for TARGETED MEDICAL PHARMA, INC.
02/04/2016 4 Wenkart Thomas Richard (10% Owner) has filed a Form 4 on Targeted Medical Pharma, Inc.
11/13/2015 10-Q Quarterly Report for the period ended September 30, 2015
10/01/2015 8-K Quarterly results
08/13/2015 10-Q Quarterly Report for the period ended June 30, 2015
05/15/2015 10-Q Quarterly Report for the period ended March 31, 2015
04/14/2015 10-K Annual Report for the period ended December 31, 2014
03/03/2015 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "To the Board of Targeted Medical Pharma, Inc. and"
02/27/2015 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Promissory Note",
"Promissory Note"
02/11/2015 SC 13G/A DERMA MEDICAL SYSTEMS INC. reports a 17.2% stake in TARGETED MEDICAL PHARMA, INC.
02/06/2015 8-K Resignation/termination of a director
01/20/2015 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits
Docs: "Form of Securities Purchase Agreement",
"Form of Senior Secured Convertible Debenture",
"Form of Security Agreement"
01/12/2015 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
01/07/2015 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
01/06/2015 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
11/14/2014 10-Q Quarterly Report for the period ended September 30, 2014
08/14/2014 10-Q Quarterly Report for the period ended June 30, 2014
06/11/2014 8-K Submission of Matters to a Vote of Security Holders
05/20/2014 10-Q Quarterly Report for the period ended March 31, 2014
05/20/2014 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Presentation"
04/30/2014 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/09/2014 SC 13G DERMA MEDICAL SYSTEMS INC. reports a 9.2% stake in TARGETED MEDICAL PHARMA, INC.
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy